RISKS, BENEFITS, AND GENERIC SUBSTITUTION

被引：6
|
作者：
CARROLL, NV [1 ]
WOLFGANG, AP [1 ]
机构：
[1] UNIV GEORGIA,DEPT PHARM CARE ADM,ATHENS,GA 30602
来源：
JOURNAL OF CONSUMER AFFAIRS | 1991年 / 25卷 / 01期
关键词：
D O I：
10.1111/j.1745-6606.1991.tb00284.x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
Consumers would save on prescriptions if pharmacists dispensed generic drugs more frequently. This study examined the relationship between pharmacists' perceptions of risks and benefits of generic substitution and their substitution behavior. Data gathered by a mail survey indicated that pharmacists' perceptions of probabilities of benefits and risks were significantly related to substitution behaviors. Pharmacists were most concerned with performance and psychological risks and financial and psychological benefits. Copyright © 1991, Wiley Blackwell. All rights reserved
引用
收藏
页码：110 / 121
页数：12
相关论文
共 50 条
  • [1] Generic substitution: risks to the pharmacist?
    Guy, C.
    Grangier, S.
    Espesson, B.
    Beyens, M.
    Mounier, G.
    Marsille, F.
    Mismetti, P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 67 - 67
  • [2] Risks and Benefits of Generic Antiepileptic Drugs
    Gomez-Alonso, Juan
    Kanner, Andres M.
    Luis Herranz, Jose
    Molins, Albert
    Gil-Nagel, Antonio
    [J]. NEUROLOGIST, 2008, 14 (06) : S66 - S72
  • [3] Risks and uses of generic substitution in epilepsy therapy
    Steinhoff, B. J.
    Runge, U.
    Witte, O. W.
    Stefan, H.
    Hufnagel, A.
    Mayer, T.
    Kraemer, G.
    [J]. NERVENHEILKUNDE, 2009, 28 (06) : 399 - 402
  • [4] PERCEIVED RISKS AND PHARMACISTS GENERIC SUBSTITUTION BEHAVIOR
    CARROLL, NV
    SIRIDHARA, C
    FINCHAM, JE
    [J]. JOURNAL OF CONSUMER AFFAIRS, 1986, 20 (01) : 36 - 47
  • [5] Generic substitution of tacrolimus after renal transplantation: A decision-making model to weigh risks and benefits
    Fonseca, M.
    Duchesne, I
    Bacaltchuk, J.
    Araujo, G.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A104 - A104
  • [6] Generic drugs: The benefits and risks of making the switch
    Lewek, Pawel
    Kardas, Przemyslaw
    [J]. JOURNAL OF FAMILY PRACTICE, 2010, 59 (11): : 634 - 640
  • [7] THE RISKS AND COSTS OF MULTIPLE-GENERIC SUBSTITUTION OF TOPIRAMATE
    Sethi, Nitin K.
    Torgovnick, Josh
    Sethi, Prahlad K.
    Arsura, Edward
    [J]. NEUROLOGY, 2010, 74 (08) : 701 - 701
  • [8] The risks and costs of multiple-generic substitution of topiramate
    Duh, M. S.
    Paradis, P. E.
    Latremouille-Viau, D.
    Greenberg, P. E.
    Lee, S. P.
    Durkin, M. B.
    Wan, G. J.
    Rupnow, M. F. T.
    LeLorier, J.
    [J]. NEUROLOGY, 2009, 72 (24) : 2122 - 2129
  • [9] The risks of multiple generic substitution of antiepileptic drugs : The case of topiramate
    Lelorier, J.
    Duh, M. S.
    Paradis, P. E.
    Latremouille-Viau, D.
    Sheehy, O.
    Greenberg, P.
    Lee, S. P.
    Rupnow, M. F.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A151 - A151
  • [10] GENERIC PRESCRIBING, GENERIC SUBSTITUTION, AND THERAPEUTIC SUBSTITUTION
    不详
    [J]. PEDIATRICS, 1987, 79 (05) : 835 - 835
12345